Helping patients access therapy as efficiently as possible is critical to improving outcomes. This is just one of the reasons electronic benefit…
Read more: How to evaluate electronic benefit verification solutions
Resource center
Featured resource
Inside the future of patient engagement
Healthcare leaders from Pfizer, AbbVie, Optum RX, Amazon Pharmacy, and more share where AI is already working in patient support and where the industry still has work to do..
SAN FRANCISCO – August 7, 2024 – Infinitus has been named the winner of a Silver Stevie® Award in the Healthcare Technology – Technology…
Read more: Infinitus named 2024 Silver Stevie® Award winner for Healthcare Technology Excellence
We’re excited to announce our AI eBV+ solution for patients covered by commercial insurance seeking access to specialty medications. Along with…
Read more: NEW! AI eBV+ for patients covered by commercial insurance
Frequently, our customers have described the Infinitus AI agent as a super-productive member of their teams. And while we focus on creating…
Read more: 2024 performance review: Infinitus AI agent Eva Lightyear
We often speak about the importance of humans in the loop in AI, and how Infinitus uses humans in concert with our purpose-built AI system. Our…
Infinitus is a healthcare AI company, but humans play a number of key roles in delivering a seamless experience to our customers and those who…
Our customers have referred to Infinitus voice AI agents as the best performers on their team. And while these AI agents may seem like magic to…
Read more: Knowledge graph is power: How Infinitus systematically increases accuracy of data outputs
Today, more than 34.2 million Americans are enrolled in original Medicare plans. This can create a challenge for pharma hubs, pharmaceutical manufacturers…
Read more: NEW! Instant AI benefit verification solution for Medicare Part B
The Inflation Reduction Act – or IRA – contains $500 billion in new funding and tax breaks intended to boost clean energy, strengthen taxpayer…
Read more: Lower costs, higher demand? What pharma and patient support need to know about the IRA
